Semaglutide, an FDA-approved treatment for Type 2 diabetes, delivers impressive results in restoring metabolic function and supporting significant weight loss.
$485.00
Semaglutide is an FDA-approved treatment for Type 2 diabetes and insulin resistance. It is a glucagon-like peptide (GLP-1) analog that enhances insulin secretion, supports pancreatic health, and slows gastric motility, increasing satiety and promoting weight loss. Semaglutide also inhibits glucagon production, helping maintain stable blood glucose levels. At higher doses, it suppresses appetite by acting on brain centers.
Key Benefits: